PION PION 深 沪
已收盘 06-05 16:00:00 美东时间
0.00
0.000
NaN.00%
华盛通- 最 高--
- 今 开--
- 成交量 0股
- 最 低 --
- 昨 收 0.00
- 总市值 0
- 52周最高 0.00
- 市盈率 静 --
- 换手率 NaN.00%
- 52周最低 0.00
- 委 比 0.00%
- 总股本 0
- 历史最高 0.00
- 量 比 0
- 振 幅 NaN.00%
- 历史最低 0.00
- 每 手 1
- 风险率
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多波士顿科学(BSX)股票3月26日盘中上涨3.66%：背后推手曝光
• Stifel重申对波士顿科学的“买入”评级，目标价为90.00美元。 • 分析师维持积极评级，目标价区间在92美元至120美元之间。 • 以145亿美元收购Penumbra预计将提振其心血管产品组合。
03-26 19:16
Boston Scientific Corp Stock (BSX) Moved Up by 3.66% on Mar 26: Key Drivers Unveiled
• Stifel reiterated a Buy rating with a $90.00 price target on Boston Scientific. • Analysts maintain positive ratings with price targets ranging from $92 to $120. • Acquisition of Penumbra for $14.5 billion is expected to boost cardiovascular portfolio.
03-26 19:15
Oculis to Present at Upcoming North American Neuro-Ophthalmology Society Annual Meeting
Oculis Holding AG announced the presentation of Phase 2 ACUITY trial results for Privosegtor at the NANOS 2026 Annual Meeting, showcasing significant improvements in low-contrast visual acuity and neuroprotective effects in patients with optic neuritis (ON). Privosegtor, a novel peptoid small molecule, has the potential to become the first neuroprotective therapy for ON, with Breakthrough Therapy designation from the FDA. The trial results highli...
03-16 09:00
Oculis Reports Q4 and Full Year 2025 Financial Results and Provides Company Update
Oculis Holding AG reported significant achievements in 2025, including clinical progress across its late-stage portfolio and a strategic expansion into neuro-ophthalmology. The company highlighted breakthrough therapy designation for Privosegtor in optic neuritis, Phase 3 DIAMOND trials for OCS-01 in diabetic macular edema (DME), and the initiation of Licaminlimab's genotype-based registrational trial for dry eye disease (DED). Cash reserves reac...
03-03 21:05
EXPLAINER-Motor racing-What's changed as Formula One enters a new era
EXPLAINER-Motor racing-What's changed as Formula One enters a new era By Alan Baldwin LONDON, March 2 (Reuters) - The 2026 Formula One season fires up in Melbourne on March 8 with the Australian Grand Prix. The following looks at what has changed in a new era for the sport: NEW CHAMPION McLaren's wo
03-02 20:44
BRIEF-Blackstone Announces Agreement To Acquire Champions Group
BRIEF-Blackstone Announces Agreement To Acquire Champions Group Feb 17 (Reuters) - Blackstone Inc BX.N : BLACKSTONE ANNOUNCES AGREEMENT TO ACQUIRE CHAMPIONS GROUP BLACKSTONE - TERMS OF TRANSACTION WERE NOT DISCLOSED Source text: ID:nBwblbZxva Further company coverage: BX.N (( Reuters.Briefs@thomsonr
02-17 22:13
Germany's PNE loses bid for Vietnam wind project, in new blow to foreign investors
Germany's PNE loses bid for Vietnam wind project, in new blow to foreign investors Newly created subsidiary of Vingroup wins bid for major wind project PNE had invested millions of dollars, was asked unexpected financial guarantees, sources say Vietnam seeks to boost national champions in new growth
02-06 13:07
BRIEF-Champion Homes Announces Third Quarter Fiscal 2026 Results
BRIEF-Champion Homes Announces Third Quarter Fiscal 2026 Results Feb 3 (Reuters) - Champion Homes Inc SKY.N : CHAMPION HOMES ANNOUNCES THIRD QUARTER FISCAL 2026 RESULTS Source text: ID:nBw8bySMCa Further company coverage: SKY.N (( Reuters.Briefs@thomsonreuters.com ;))
02-04 05:25
SLB beats Q4 revenue, adj EPS expectations, plans to return $4 bln to shareholders in 2026
SLB beats Q4 revenue, adj EPS expectations, plans to return $4 bln to shareholders in 2026 Overview Oilfield services firm's Q4 revenue rose 5% yr/yr, beating analyst expectations Adjusted EPS for Q4 beat analyst expectations Company plans to return over $4 bln to shareholders in 2026 Outlook SLB ex
01-23 19:58
BRIEF-Invivyd Partners With Lindsey Vonn To Educate Americans On Antibodies And Disease Prevention
BRIEF-Invivyd Partners With Lindsey Vonn To Educate Americans On Antibodies And Disease Prevention Jan 22 (Reuters) - Invivyd Inc IVVD.O : INVIVYD ANNOUNCES PARTNERSHIP WITH WORLD CHAMPION SKIER LINDSEY VONN TO EDUCATE AMERICANS ON ANTIBODIES AND DISEASE PREVENTION Source text: ID:nGNX2N0g53 Further
01-22 20:24
